CEO Michael Kauffman sold $275K of Karyopharm Therapeutics Inc.

Sold$274,690

$18.31Price

15,000Shares

−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Wed, Jun 10. Filed Thu, Jun 11, 12:39 PM ET, during the session. Not investment advice.